INSIGHTS ON DRUG DEVELOPMENT
-
EMA Support For SMEs Through Scientific Advice And Early Dialogue
Discover how early engagement with European regulators helps smaller drug developers reduce uncertainty, clarify requirements, and deārisk innovative programs through early dialogue.
-
Comprehensive Workflow For The Quantification Of Peptides And Proteins
Biologics are transforming medicine, with semaglutide leading the way. Discover how an automated LC-MS/MS workflow enables high-sensitivity quantification of peptides in plasma.
-
History Of Peptides In Medicine: From Early Chemistry To The GLP-1 Era
Peptide therapeutics from early chemical breakthroughs to today’s metabolic drugs, highlighting scientific, clinical, and manufacturing advances shaping modern drug development.
-
How To Reduce Batch Loss In Biopharma Production
Batch failures in biopharma remain costly despite improvements. Learn the leading causes in downstream purification and how supplier expertise can help reduce risk and protect production.
-
Integrating Phase-Appropriate Quality Standards12/9/2024
Incorporating phase-specific quality standards ensures GMP compliance. Collaborating with an experienced CDMO addresses late-stage quality needs and efficiently manages development timelines.
-
Step-By-Step Guide To Tech Transfer Preparation And Execution10/31/2024
How does a sponsor accurately transfer detailed knowledge about its product composition, development, and current manufacturing processes to its CDMO?
-
Is Lipinski's Rule Of Five Still Relevant In Drug Development?11/13/2024
Some drugs violate multiple Ro5 elements but remain developable, while some molecules adhere strictly to the Ro5, but their properties are not conducive to development.
-
Inside Bioprocessing: Continuous Perfusion11/4/2025
Learn about the essential elements of upstream workflows, media optimization strategies, and liquid handling logistics required to implement continuous perfusion successfully.
-
Managing Process Knowledge Throughout Drug Development And Manufacturing10/21/2025
Discover how digitalizing recipe and risk management helps life sciences teams accelerate drug development, streamline technology transfers, and simplify compliance to improve data integrity.
DRUG DEVELOPMENT SOLUTIONS
-
Everything we do for our customers is driven by an unswerving belief that ideas need to become solutions, molecules need to become cures, fast. Because humanity needs solutions, fast.
-
Gain human-relevant insights with patient-derived assay-ready organoids.
-
SimpleStep ELISA® kits are sandwich ELISA assays that we have developed to be as simple and effective as possible. Unlike traditional sandwich ELISAs, which take more than three hours to run, SimpleStep ELISA kits generate data in just 90 minutes without compromising performance, using only one wash step and recombinant antibodies for exceptional specificity.
-
Designed for today’s assays and tomorrow’s breakthroughs—flexible detection that evolves with your science.
The SpectraMax® iD3s and iD5e Multi-Mode Microplate Readers deliver flexible, scalable solutions for absorbance, fluorescence, and luminescence assays—with advanced capabilities for evolving research needs. The iD3s reader offers a streamlined, affordable platform with a tunable monochromator and temperature control, while the iD5e reader adds enhanced detection modes including time-resolved fluorescence (TRF) and tunable fluorescence polarization (FP) and can be expanded to include TR-FRET, HTRF, BRET and western blot. Both readers support on board fluidics with optional dual injectors.
-
Review three of our key compounds — Testosterone Base, Testosterone Cypionate, and Testosterone Propionate — each presented with essential identifiers such as CAS numbers, structural features, and typical marketed dosage forms.